Repligen
RGEN
#2397
Rank
NZ$13.54 B
Marketcap
NZ$239.93
Share price
-1.80%
Change (1 day)
19.41%
Change (1 year)
Categories

Market capitalization of Repligen (RGEN)

Market cap: NZ$13.54 Billion

As of August 2026 Repligen has a market cap of NZ$13.54 Billion. This makes Repligen the world's 2397th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Repligen from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$13.54 B-16.18%
2025NZ$16.15 B11.73%
2024NZ$14.45 B-8.92%
2023NZ$15.87 B7.21%
2022NZ$14.80 B-30.93%
2021NZ$21.43 B47.52%
2020NZ$14.53 B103.17%
2019NZ$7.15 B107.14%
2018NZ$3.45 B55.16%
2017NZ$2.22 B47.84%
2016NZ$1.50 B10.53%
2015NZ$1.36 B64.44%
2014NZ$0.82 B56.29%
2013NZ$0.52 B122.52%
2012NZ$0.23 B74.38%
2011NZ$0.13 B-27.04%
2010NZ$0.18 B7.52%
2009NZ$0.17 B-14.3%
2008NZ$0.20 B-23.51%
2007NZ$0.26 B119.11%
2006NZ$0.12 B-31.23%
2005NZ$0.17 B45.18%
2004NZ$0.12 B-39.69%
2003NZ$0.20 B26.74%
2002NZ$0.15 B1.61%
2001NZ$0.15 B-22.81%
2000NZ$0.20 B51.69%
1999NZ$0.13 B205.04%
1998NZ$43.75 M80.61%
1997NZ$24.22 M-9.4%
1996NZ$26.74 M

End of Day market cap according to different sources

On Aug 1st, 2026 the market cap of Repligen was reported to be:

NZ$13.54 Billion
by Nasdaq info icon info icon
NZ$13.54 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$242.53 B 1,691.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$363.13 B 2,581.86%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$635.67 B 4,594.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$226.92 B 1,575.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$52.16 M-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$2.04 B-84.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$28.53 B 110.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$19.11 B 41.15%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$19.73 B 45.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
NZ$19.05 B 40.73%๐Ÿ‡บ๐Ÿ‡ธ USA